Nordmann News & Events News Sustainability with Nordmann-partner Mingtai
24 January 2024

Sustainability with Nordmann partner Mingtai

For decades, Nordmann partner Mingtai has been one of the leading manufacturers of pharmaceutical excipients that include Comprecel® Microcrystalline cellulose and other cellulose products. In addition to its production activities, the company maintains a focus on responsible environmental management and sustainable development. Mingtai in fact adopted the ISO 14001 environmental management system several years ago in an effort to fulfill its social responsibility and help protect the planet.

Headquartered in Taiwan, the company is committed to safeguarding the habitats of living creatures and preserving the natural ecology around its production facilities – which is why it has been taking environmental protection measures for such a long time already. From sewage and waste management to preventing air and noise pollution, all of the measures that Mingtai follows comply with the requirements of national environmental regulations.

World map out of leaves with graphics in the background

Greening its factory premises and the surrounding area is also an important company focus. Green spaces cover around 30% of Mingtai’s production site in Hukou, for instance, and the facilities there offer several examples of environmentally friendly construction. Multi-layered glass façades covered with screen-printed film provide thermal insulation against solar radiation, for example, and energy-efficient equipment is utilized in its wastewater treatment plant. In addition, the Hukou site uses reverse osmosis (RO) wastewater from this same treatment plant to water its spacious green areas.

 

Mingtai also efficiently utilizes power – primarily electricity and liquefied natural gas (LNG) – and consistently implements measures to save energy and reduce carbon emissions. Adhering to ISO 14001 regulations and complying with operational regulations on air pollution control also help Mingtai lower its greenhouse gas emissions.

 

The company further supports environmental protection when it comes to packaging materials and to raising awareness of resource conservation. For example, it utilizes recyclable raw materials for pallets and packaging strips that can be reused by customers.

 

Nordmann distributes Mingtai’s raw materials for pharmaceuticals and food in Austria, Croatia, the Czech Republic, Germany, Ireland, Macedonia, the Nordic countries, Poland, Serbia, Slovakia, Slovenia and Switzerland.

 

Nordmann’s portfolio features the following Mingtai products:

  • Comprecel® Microcrystalline Cellulose
  • Comprecel® SMCC Silicified Microcrystalline Cellulose
  • Disolcel® CCS Croscarmellose Sodium
  • Neocel® Microcrystalline Cellulose and Carboxymethylcellulose Sodium

For more information, please contact:

Sabine Hartmann
Sabine Hartmann
Senior Technical Sales & Product Manager | Health Care
Nordmann, Rassmann GmbH

This might also interest you:

SPOTLIGHT ON SUSTAINABILITY
12 March 2024

Nordmann partner Cell Biotech focuses on sustainability

For Cell Biotech, sustainability matters. Headquartered in Korea, the company pursues a variety of initiatives to protect the environment, reduce energy consumption and conserve resources.
SPOTLIGHT ON SUSTAINABILITY
24 January 2024

Sustainability with Nordmann partner Mingtai

For decades, Nordmann partner Mingtai has been one of the leading manufacturers of pharmaceutical excipients that include Comprecel® Microcrystalline cellulose and other cellulose products. In addition to its production activities, the company maintains a focus on responsible environmental management and sustainable development. Mingtai in fact adopted the ISO 14001 environmental management system several years ago in an effort to fulfill its social responsibility and help protect the planet.
SPOTLIGHT ON SUSTAINABILITY
8 November 2023

Positive climate change with IOI Oleo

Nordmann partner IOI Oleo is a leading manufacturer of oleochemical and pharmaceutical raw materials such as excipients and active pharmaceutical ingredients (APIs) – and one that is aware of the environmental and social impact its business can have on future generations.